Our findings suggest that miR-224 acts as a tumor promoter in cervical cancer, and that miR-224 and its target RASSF8 protein have potential for use as prognostic predictors or therapeutic targets in cervical cancer patients. The gene discussed is RASSF8; the disease is cervical cancer.